Evidence map›Paper›PMID 41105328›Full record

ReviewJournal of materials science. Materials in medicine2025

Advances in hyaluronic acid-based biomaterials: applications in cancer therapy, wound healing, and disease management.

Li Wang, Fei Zhou, Weimin Xie

Abstract readReview
In one paragraph

Review in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Polysaccharides and carbohydrate polymers: innovations from nature to industry.Journal of the science of food and agriculture · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Natural Polymers in Guided Bone Regeneration (GBR).Journal of functional biomaterials · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Polysaccharide based biomaterials for advanced wound healing applications.Frontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li WangDepartment of Gynecology, Tongren People's Hospital, Tongren, Guizhou, China.
Fei ZhouDepartment of Gynecology, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan, China. zhoufei2022123@163.com.
Weimin XieDepartment of Gynecology, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan, China. doctorxie315@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan and is essential in biomedical research due to its distinct properties, compatibility with biological tissues, and functions in preserving tissue hydration, lubrication, and the integrity of the extracellular matrix, a significance recognized since 1934. Its capability to develop hydrogels and react to environmental factors has provided it a strong factor for drug delivery, tissue engineering, and wound healing uses. This review emphasizes the various biomedical uses of HA-based materials, focusing on their functions in cancer treatment, wound healing, inflammation control, antibacterial properties, and antioxidant functions. In cancer treatment, HA-functionalized nanoparticles improve the targeted drug delivery by using the additional presence of CD44 receptors in cancer cells. HA-based hydrogels have demonstrated significant potential in advancing wound healing by regulating inflammatory responses, enhancing angiogenesis, and participating in the extracellular matrix remodeling. Moreover, HA's anti-inflammatory and antioxidant characteristics have been utilized in the treatment of chronic inflammatory conditions including osteoarthritis and inflammatory bowel disease. The recent developments in HA-based materials have also demonstrated their promise in antibacterial applications, diabetes control, and in treating cardiovascular and neurological conditions. The advancement of HA-based intelligent drug delivery systems and bioactive scaffolds is ongoing, presenting new treatment options for tissue repair and disease management. This review emphasizes the diverse functions of HA in both health and disease, showcasing its capacity to tackle various medical issues through cutting-edge biomedical applications.

Indexed as

Biocompatible MaterialsHyaluronic AcidNeoplasmsWound HealingAnimalsAntioxidantsDisease ManagementDrug Delivery SystemsHumansHydrogelsNanoparticlesTissue EngineeringAntioxidantsBiocompatible MaterialsHyaluronic AcidHydrogels

Identifiers

PMID41105328
PMCPMC12534349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.